Paper61440
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer.
Purcell RH and 10 others. Lancet, 1976. Cited by 82 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer. Papers, record 61440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/61440
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon Inducers | Major topic |
| Poly I-C | Major topic |
| Animals | |
| Chronic Disease | |
| Inclusion Bodies, Viral | |
| Interferons | |
| Liver | |
| Pan troglodytes |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,210,021 | In Vitro Systems for Studying Different Genotypes/Sub-Genotypes of Hepatitis B Virus: Strengths and Limitations. | Viruses | 2020 | https://conductscience.org/library/papers/32210021 | PubMed |
| 29,444,493 | Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B. | Curr Opin Virol | 2018 | https://conductscience.org/library/papers/29444493 | PubMed |
| 29,337,856 | Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B. | Vaccines (Basel) | 2018 | https://conductscience.org/library/papers/29337856 | PubMed |
| 26,186,123 | Host-virus interactions in hepatitis B virus infection. | Curr Opin Immunol | 2015 | https://conductscience.org/library/papers/26186123 | PubMed |
| 26,033,082 | The chimpanzee model for hepatitis B virus infection. | Cold Spring Harb Perspect Med | 2015 | https://conductscience.org/library/papers/26033082 | PubMed |
| 25,418,467 | Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. | Cell Mol Immunol | 2015 | https://conductscience.org/library/papers/25418467 | PubMed |
| 19,360,120 | Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. | PLoS Pathog | 2009 | https://conductscience.org/library/papers/19360120 | PubMed |
| 10,666,256 | Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. | J Virol | 2000 | https://conductscience.org/library/papers/10666256 | PubMed |
| 7,380,332 | Liver disease and the e antigen in HBsAg carriers with chronic renal failure. | Gut | 1980 | https://conductscience.org/library/papers/7380332 | PubMed |
| 6,253,403 | Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus. | Infect Immun | 1980 | https://conductscience.org/library/papers/6253403 | PubMed |
| 6,157,363 | Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6157363 | PubMed |
| 631,632 | Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. | Gut | 1978 | https://conductscience.org/library/papers/631632 | PubMed |
| 334,285 | Interferons: anti-neoplastic drugs? | Blut | 1977 | https://conductscience.org/library/papers/334285 | PubMed |
| 196,274 | Recent advances in the identification of hepatitis viruses. | Postgrad Med J | 1977 | https://conductscience.org/library/papers/196274 | PubMed |
| 91,092 | The hepatitis B virus and its DNA polymerase: the prototype three-D virus. | Mol Cell Biochem | 1979 | https://conductscience.org/library/papers/91092 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/61440
GET https://conductscience.org/api/papers/v1/61440/authors